National Kidney Foundation Innovation Fund Invests in Revalia Bio to Advance Innovative Kidney Disease Therapeutics ...Middle East

PR Newswire - Economy
National Kidney Foundation Innovation Fund Invests in Revalia Bio to Advance Innovative Kidney Disease Therapeutics
NEW YORK, Oct. 17, 2024 /PRNewswire/ -- The National Kidney Foundation (NKF) Innovation Fund is proud to announce its latest investment in Revalia Bio, an innovative health technology company focused on creating a new paradigm in how we develop and deliver personalized care for kidney...

Hence then, the article about national kidney foundation innovation fund invests in revalia bio to advance innovative kidney disease therapeutics was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( National Kidney Foundation Innovation Fund Invests in Revalia Bio to Advance Innovative Kidney Disease Therapeutics )

Apple Storegoogle play

Last updated :

Also on site :



Latest News
before 3 hours & 46 minute